Cornea

Five-year follow-up after epi-off accelerated cross-linking showed keratoconus stability, with meaningful improvement of vision, corneal curvature and higher-order aberrations in a group of pediatric and young adult patients.

In this video, Jodhbir Mehta, MD, PhD, gives a detailed account of upcoming promising developments of artificial intelligence in anterior segment disease management, surgery and novel therapies.

In this video, Shigeru Kinoshita, MD, PhD, speaks about the latest results of cell injection therapy using cultured human corneal endothelial cells.

Innovative antibiotics and antimicrobial peptides may dispel the threat of antibiotic resistance, but a joint effort of governments with the pharmaceutical industry is required, according to one presenter at the virtual EuCornea congress.

As elective corneal transplantation procedures resume, eye banks continuously monitor the evolution of the COVID-19 pandemic and update their guidance and screening recommendations, while cornea practices enhance safety measures.

Healio/OSN published several cornea and external disease articles throughout August. Here are five of the most-read items.

Patients who underwent a single 5-minute warm compress therapy experienced improved ocular surface characteristics, according to a poster at the virtual Women in Ophthalmology Summer Symposium.

Patients treated with a fourth-generation fluoroquinolone for MRSA keratitis experienced similar visual acuity outcomes as those treated with vancomycin, according to a presenter at the virtual Association for Research in Vision and Ophthalmology meeting.

Marian Macsai, MD, a cornea specialist at NorthShore University HealthSystem in Chicago, shows and discusses physicians’ use of personal protective equipment and how they have restructured their eye care treatment procedures during the COVID-19 pandemic.

Marian Macsai, MD, a cornea specialist at NorthShore University HealthSystem in Chicago, discusses how some patients with COVID-19 developed a distinct version of viral conjunctivitis and how they are treating those patients.